MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis

    M. Alsaied, A. Elettreby, A. Abo Elnaga, D. Kamal, G. Alderbi, A. Sharkawy, R. Fareed (Mansoura, Egypt)

    Objective: The objective of this systematic review and meta-analysis of published clinical trials is to investigate the probiotics' efficacy in treating constipation in Parkinson’s patients.…
  • 2023 International Congress

    Dyskinesia and adherence to safinamide and opicapone in fluctuating patients with Parkinson’s disease: observational retrospective study

    P. Lorenzo-Barreto, I. Pareés, P. Pérez-Torre, S. Fanjul, JL. López-Sendón, F. Pérez-Trapote, A. Sáez-Marín, E. Stiauren-Fernández, á. Patiño-Patón, JC. Martínez-Castrillo, A. Alonso-Cánovas (Madrid, Spain)

    Objective: To assess differences in the new onset or worsening of baseline dyskinesia after the introduction of safinamide (SA) or opicapone (OP) as add-on therapy…
  • 2023 International Congress

    Is STN a good target for decrease off period by DBS, Gpi – for reduction of dyskinesia in PD patients?

    A. Buniak, V. Alexeyevets, S. Likhachev, V. Bayarchyk (Minsk, Belarus)

    Objective: To study the efficiency of DBS GPI in PD patients compared to DBS STN in Republican center of neurology and neurosurgery in Belarus Background:…
  • 2023 International Congress

    Comparison of the MIBG uptake in the major salivary glands between progressive supranuclear palsy/corticobasal syndrome and Parkinson’s disease

    J. Ebina, M. Shibukawa, H. Morioka, J. Nagasawa, M. Yanagihashi, T. Hirayama, N. Ishii, S. Mizumura, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: To compare the MIBG uptake in the major salivary gland between progressive supranuclear palsy/corticobasal syndrome (PSP/CBS) and Parkinson’s disease (PD). Background: 123I-metaiodobenzylguanidine (MIBG) myocardial…
  • 2023 International Congress

    A qualitative study exploring the feasibility of exergames among persons with Parkinson’s disease

    C. Chung, J. Poh, Z. Yee, S. Neo (Singapore, Singapore)

    Objective: The study aims to compare the usability of a newly developed exergame application designed for people with Parkinson’s disease (PD) to existing commercial games,…
  • 2023 International Congress

    Describing the syndrome: a comprehensive analysis of a large cohort of corticobasal syndrome with pathological correlation

    D. Vaughan, M. Theilmann Jensen, D. Lux, L. Wu, Z. Jaunmuktane, T. Revesz, T. Lynch, M. Stamelou, K. Seppi, R. Vandenberghe, T. Warner, K. Bhatia, A. Lees, A. Church, N. Leigh, P. Taba, T. Matsalu, P. Mir, B. Ghosh, M. Picillo, J. Wallin, P. Svenningsson, Y. Compta, J. Rohrer, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To describe the clinical, biomarker, genetic and pathological features of a cohort of patients with corticobasal syndrome (CBS). Background: Corticobasal degeneration (CBD) was first…
  • 2023 International Congress

    Piloting the Cats-and-Dogs tool as a culture-fair test for sensory processing impairment in Parkinson’s disease

    D. Mair, K. Dey, E. Camboe, A. Zirra, R. Weil, D. Gallagher, C. Budu, T. Haque, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: This pilot explored the feasibility and culture-fairness of a psychophysical visuoperceptual test for Parkinson’s disease (PD) in a multicultural population in East London. Background:…
  • 2023 International Congress

    Correlation between levels of plasma neurofilament light chain and freezing of gait in Parkinson’s disease

    Y. Zhu, X. Yang, H. Ren, A. Pang (Kunming, China)

    Objective: This study evaluated the correlation between neurofilament light chain (NfL) and freezing of gait (FOG) in Parkinson's disease (PD). Background: PD patients frequently experience…
  • 2023 International Congress

    Protein X: a key player in Parkinson’s Disease pathophysiology? – insights from compound screening in gba1 knock-out medaka

    E. Nakanishi, T. Taguchi, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: This experiment was conducted to elucidate the molecular pathogenesis of Parkinson's disease (PD) and identify potential treatments. Background: PD is one of the most…
  • 2023 International Congress

    TELO2 defect presenting with childhood-onset complex hyperkinetic MD

    M. Novelli, S. Galosi, R. Carrozzo, L. Travaglini, L. Pollini, C. Caputi, F. Pisani, V. Leuzzi (Rome, Italy)

    Objective: Expanding the TELO2-related phenotype by presenting a case with prominent hyperkinetic MD. Background: Telomere maintenance 2 (TELO2), Tel2 interacting protein 2 (TTI2), and Tel2…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley